IBDEI1ED ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25055,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,25056,0)
 ;;=196.0^^145^1535^100
 ;;^UTILITY(U,$J,358.3,25056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25056,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,25056,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,25056,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,25057,0)
 ;;=196.1^^145^1535^101
 ;;^UTILITY(U,$J,358.3,25057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25057,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,25057,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,25057,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,25058,0)
 ;;=196.8^^145^1535^102
 ;;^UTILITY(U,$J,358.3,25058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25058,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,25058,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,25058,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,25059,0)
 ;;=V10.51^^145^1535^56
 ;;^UTILITY(U,$J,358.3,25059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25059,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,25059,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,25059,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,25060,0)
 ;;=V10.3^^145^1535^57
 ;;^UTILITY(U,$J,358.3,25060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25060,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,25060,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,25060,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,25061,0)
 ;;=V10.41^^145^1535^58
 ;;^UTILITY(U,$J,358.3,25061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25061,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,25061,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,25061,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,25062,0)
 ;;=V10.05^^145^1535^59
 ;;^UTILITY(U,$J,358.3,25062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25062,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,25062,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,25062,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,25063,0)
 ;;=V10.03^^145^1535^60
 ;;^UTILITY(U,$J,358.3,25063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25063,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,25063,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,25063,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,25064,0)
 ;;=V10.60^^145^1535^62
 ;;^UTILITY(U,$J,358.3,25064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25064,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,25064,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,25064,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,25065,0)
 ;;=V10.11^^145^1535^63
 ;;^UTILITY(U,$J,358.3,25065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25065,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,25065,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,25065,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,25066,0)
 ;;=V10.79^^145^1535^64
 ;;^UTILITY(U,$J,358.3,25066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25066,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,25066,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,25066,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,25067,0)
 ;;=V10.82^^145^1535^65
 ;;^UTILITY(U,$J,358.3,25067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25067,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,25067,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,25067,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,25068,0)
 ;;=V10.02^^145^1535^68
 ;;^UTILITY(U,$J,358.3,25068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25068,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,25068,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,25068,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,25069,0)
 ;;=V10.43^^145^1535^69
